Agenda

Skip to content

Programs & Resources

The Early Detection Research Network (EDRN) Steering Committee Meeting

Agenda

Tuesday, September 03, 2002
4:00 - 6:00 pm	Subcommittee Meetings (Chair to collect all information prior to the meeting in consultation with NCI Staff) Prioritization Subcommittee:Discussion on Network Consulting Committee Meeting Collaboration and Publication Subcommittee: Listing of Collaborative Activities across the Network Technology and Resource Sharing Subcommittee: Tissue and Protein Arrays Communication Subcommittee:Gordon Research Conference Data Sharing & Informatics Subcommittee: Discussion onwillingness to share data and the peer review system beginning to take this into consideration when scoring grant applications, and discussion on EDRN specimen search tool
7:30 - 9:00 pm	ER Negative Breast Cancer Mini-Symposium

Wednesday, September 04, 2002
7:00 - 8:00 am	Registration and Continental Breakfast
8:00 - 8:10 am	Welcome & Approval of February 2002 SC minutes: Peter Greenwald/David Sidransky
8:10 - 8:25 am	Introduction: Allen Lichter, MD, Dean, University of Michigan Medical School, and Max Wicha, MD, Director, University of Michigan Comprehensive Cancer Center
8:25 - 8:45 am	EDRN Updates: Sudhir Srivastava
8:45 - 9:30 am	DMCC Updates (website update, CDE database? IRB?)
9:30 - 9:40 am	Presentations on Upcoming Network Consulting Committee Meeting: Sudhir Srivastava
9:40 - 10:30 am	NCI Intramural and EDRN Collaboration: Carl Barrett, Director, Clinical Research Center, NCI
10:30 - 10:45 am	BREAK
10:45 am - 12:30 pm	Informatics Pilot Project Presentation
12:30 - 2:00 pm	LUNCH BREAK
2:00 - 5:00 pm	Collaborative Group Meetings
7:00 - 9:00 pm	Collaborative Showcase: Breast and Ovarian Cancers

Thursday, September 05, 2002
7:00 - 8:00 am	Continental Breakfast
8:00 - 8:45 am	Guest Lectures: EDRN-CCOP Collaboration: Phil Stella & Dr Worta McCaskill- Stevens, NCI
8:45 - 10:00 am	Promises and Challenges of Proteomic Technology for Biomarker Research Moderator: Peter Barker Speakers: Sam Hanash, John Semmes, Yingming Zhao Panelists: Speakers plus David Beach, David Chia, Emanuel Petricoin, Ziding Feng, Dan Chan, Zhen Zhang
10:00 - 10:15 am	BREAK
10:15 - 11:15 am	Linkage of Proteomics to Clinical Applications Moderator: Ian Thompson Panelists: David Fishman, William Bigbee, William Rom, Dan Cramer, Emanuel Petricoin, Jeremy Taylor
11:15 am - 12:15 pm	Collaborative Group & Subcommittee Reports
12:40 pm - 1:30 pm	LUNCH Discussion Updates on CGN-EDRN Collaboration: Patrice Watson Liaison Reports EORTC Standardization Report: Herb Fritsche SPORE: Adi Gazdar PCPT: Ian Thompson

EDRN Public-Private Partnership Mini-Workshop
Moderators:	Robert Smith, PhD, American Cancer Society (Chair) Paula Friedman, PhD Abbot Laboratories Jacob Kagan, MS, PhD, the NCI
1:30 - 1:40 pm	Purpose: Robert Smith, PhD/Jacob Kagan, PhD, American Cancer Society, Moderators
1:40 - 2:00 pm	Introduction: The EDRN Sudhir Srivastava, MPH, PhD the NCI
2:10 - 2:30 pm	Financing and Intellectual Property Issues: Richard Schlisky, MD, Associate Dean For Clinical Research, University of Chicago
2:30 - 2:50 pm	Mechanisms for Public-Private Partnership: Wendy Patterson, NCI Office of Technology Transfer
3:10 - 3:30 pm	Public-Private Partnership: Industrial Perspectives: Paula Friedman, Abbott Laboratories
3:30 - 3:45 pm	Break
3:45 - 4:00 pm	EDRN - Human Proteome Organization Collaboration Gilbert S Omenn, MD, PhD, Uni Of Michigan
4:15 - 4:30	Public-Private Partnership: Foundations/Advocacy Group Perspectives: Carolyn R Aldige, Cancer Research Foundation of America
4:30 - 5:00 pm	Discussion
5:00 - 7:00 pm	Break / Dinner at leisure
7:00 - 10:00 pm	Panel Discussion on Public-Private Partnership: Paula Kim, Amy McGuire For issues to be discussed, see the previous page
Note: Depending on the developing agenda and industrial input, we may need to continue this discussion on Friday for an hour or two